Itoh A, Taniguchi H, Sawai K, Takahashi T, Kawamoto K, Deguchi T, Kagawa K
First Department of Surgery, Kyoto Prefectural University of Medicine, Japan.
Gastroenterol Jpn. 1991 Aug;26(4):536-42. doi: 10.1007/BF02782826.
It is controversial whether adenomatous hyperplasia (AH) of the liver progresses to hepatocellular carcinoma. We experienced two hepatic lesions in a patient (73-yr-old male) with cirrhotic liver. One was diagnosed as HCC and the other was AH including a small HCC histologically. To investigate cell kinetics and the ploidy pattern of these lesions, Feulgen DNA-cytofluorometry analysis was performed. The result of this analysis suggested that AH developed into extremely well-differentiated HCC composed of mononuclear diploid cells at first and then was further transformed into clear cell type HCC composed of mononuclear tetraploid cells. The development of human HCC, at least in cirrhotic liver, may therefore be a multi-step process.
肝脏腺瘤样增生(AH)是否会进展为肝细胞癌存在争议。我们在一名患有肝硬化的73岁男性患者中发现了两处肝脏病变。一处被诊断为肝细胞癌,另一处从组织学上看是AH,其中包含一个小的肝细胞癌。为了研究这些病变的细胞动力学和倍体模式,我们进行了Feulgen DNA细胞荧光光度分析。该分析结果表明,AH最初发展为由单核二倍体细胞组成的高分化肝细胞癌,然后进一步转变为由单核四倍体细胞组成的透明细胞型肝细胞癌。因此,人类肝细胞癌的发生,至少在肝硬化肝脏中,可能是一个多步骤过程。